CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 60 filers reported holding CYTOSORBENTS CORP in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,266 | -47.6% | 3,333 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $11,965 | +6.5% | 3,333 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $11,232 | +117.4% | 3,333 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $5,166 | +3.3% | 3,333 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $5,000 | -28.6% | 3,333 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $7,000 | -36.4% | 3,333 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $11,000 | -21.4% | 3,333 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $14,000 | -48.1% | 3,333 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $27,000 | +8.0% | 3,333 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $25,000 | -10.7% | 3,333 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $28,000 | +7.7% | 3,333 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $26,000 | 0.0% | 3,333 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $26,000 | – | 3,333 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
| Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
| CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
| Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
| Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
| Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
| Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
| Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |